<SEC-HEADER>0001558370-17-000560.hdr.sgml : 20170213
<ACCEPTANCE-DATETIME>20170213170128
ACCESSION NUMBER:		0001558370-17-000560
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		76
CONFORMED PERIOD OF REPORT:	20161231
FILED AS OF DATE:		20170213
DATE AS OF CHANGE:		20170213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nivalis Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001626199
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				208969493
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37449
		FILM NUMBER:		17600262

	BUSINESS ADDRESS:	
		STREET 1:		3122 STERLING CIRCLE, SUITE 200
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		720-945-7700

	MAIL ADDRESS:	
		STREET 1:		3122 STERLING CIRCLE, SUITE 200
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	N30 Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20141121
</SEC-HEADER>